Paromomycin sulfate salt
SIGMA/P9297 - ≥98% (TLC)
Synonym: Aminosidine sulfate
CAS Number: 1263-89-4
Empirical Formula (Hill Notation): C23H45N5O14 · xH2SO4
Molecular Weight: 615.63 (free base basis)
Linear Formula: C23H45N5O14 · xH2SO4
Product Type: Chemical
| antibiotic activity spectrum | Gram-negative bacteria |
| Gram-positive bacteria | |
| parasites | |
| assay | ≥98% (TLC) |
| form | powder |
| InChI | 1S/C23H45N5O14.CH4/c24-2- |
| InChI key | OYJABWUHUYVDMJ-UDXJMMFXSA |
| mode of action | protein synthesis | interferes |
| Quality Level | 200 ![]() |
| SMILES string | O[C@H]1[C@H](O)[C@@H](CO) |
| Application: | Paromomycin is a broad spectrum aminoglycoside antibiotic produced by Streptomyces rimosus var. paromomycinus. It has in vitro and in vivo activity similar to neomycin. It is effective against Gram-negative bacteria, Gram-positive bacteria, some protozoan species, and limited antihelminth. It is used to study bacterial protein synthesis at the level of 16S ribosomal RNA and 30S ribosome assembly. Paromomycin is used to study cytosine-cytosine (CC) mismatch-containing RNA molecules and is used to inhibit Cryptosporidium infection of a human enterocyte cell line. |
| Biochem/physiol Actions: | Antimicrobial spectrum: Gram-negative and Gram-positive bacteria, some protozoan species, and limited antihelminth. Mode of Action: Inhibits initiation and elongation during protein synthesis. |
| Biochem/physiol Actions: | Paromomycin inhibits the initiation and elongation steps of protein synthesis by binding to 16S ribosomal RNA. Paramomycin binds to the A site, which causes defective polypeptide chains to be produced and leads to cell death. |
| General description: | Chemical structure: aminoglycoside |
| Other Notes: | Keep container tightly closed in a dry and well-ventilated place. |
| Packaging: | 1g,5g,25g |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (TLC) |
| UNSPSC | 51281663 |

